Frank J. Williams, Director at Evolent Health, Inc. (EVH), sold 220,000 shares at $29.26 ($6.5M) on 2023-06-01, disclosed to the SEC on 2023-06-05.
Scheduled sale ($6.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.26 | 41,914 | $1.2M | 18.9% |
| 2 | $29.26 | 41,914 | $1.2M | 18.9% |
| 3 | $29.27 | 9,091 | $266K | 4.1% |
| 4 | $29.27 | 9,091 | $266K | 4.1% |
| 5 | $29.74 | 49,026 | $1.5M | 22.5% |
| 6 | $29.74 | 49,026 |
| $1.5M |
| 22.5% |
| 7 | $29.75 | 9,969 | $297K | 4.6% |
| 8 | $29.75 | 9,969 | $297K | 4.6% |
| Total | $29.52 avg | 220,000 | $6.5M | 100% |
| Filing → |
| EVH | SELL | 2023-03-07 | $14.3M | — | Filing → |
| EVH | SELL | 2023-03-02 | $7.7M | — | Filing → |
| EVH | SELL | 2023-02-03 | $3.5M | — | Filing → |